FDA approves Odactra for house dust mite allergies - FDA Press Releases

The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), in people 18 through 65 years of age.

from Food and Drug Administration--Press Releases http://ift.tt/2mfzkhZ
via IFTTT